The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Linking the epigenetic ‘language’ of covalent histone modifications to cancer
Open accessAbstract
Covalent modifications of histones, such as acetylation, methylation, and phosphorylation, and other epigenetic modulations of the chromatin, such as methylation of DNA and ATP-dependent chromatin reorganisation, can play a major part in the multistep process of carcinogenesis, with far-reaching implications for human biology and human health. This review focuses on how aberrant covalent histone modifications may contribute to the development of a variety of human cancers, and discusses the recent findings with regard to potential therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 2×
“…in histone H3 can mark relatively large chromosomal domains (about 25– 50 kb) with ‘active’ vs ‘inactive’ signatures often interrupted by sharp transitions or boundaries that are poorly understood (reviewed in Jenuwein and Allis, 2001; Zhang and Reinberg, 2001; Felsenfeld and Groudine, 2003).”
BackgroundInfluentialSelf-citationCrystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Self-citationJaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098 · cited 1×
“X is phosphorylated in nucleosomes adjacent to DSBs and protein factors involved in DNA repair and signalling pathways are recruited to this site (Paull et al, 2000; Redon et al, 2002).”
BackgroundHox genes in vertebrate development
Krumlauf, R. (1994) · Cell · doi:10.1016/0092-8674(94)90290-9 · Cited by 2,073
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,530
Genomic Instability in Mice Lacking Histone H2AX
Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002) · Science · doi:10.1126/science.1069398 · Cited by 1,385
ATP-Driven Exchange of Histone H2AZ Variant Catalyzed by SWR1 Chromatin Remodeling Complex
Mizuguchi, G., Shen, X., Landry, J., Wu, W.-H., Sen, S., & Wu, C. (2004) · Science · doi:10.1126/science.1090701 · Cited by 1,309
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Histone and chromatin cross-talk
Fischle, W., Wang, Y., & Allis, C. D. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00013-9 · Cited by 1,207
Self-citationHistone acetylation and an epigenetic code
Turner, B. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<836::aid-bies9>3.0.co;2-x · Cited by 1,182
The Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 6×
“Hypophosphorylated Rb inactivates E2F in early G1 phase and becomes hyperphosphorylated during G1/S transition, resulting in the release and activation of E2F (Hanahan and Weinberg, 2000).”
BackgroundInfluentialFelsenfeld, G., & Groudine, M. (2003) · Nature · doi:10.1038/nature01411 · Cited by 1,150
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Heterochromatin and Epigenetic Control of Gene Expression
Grewal, S. I. S., & Moazed, D. (2003) · Science · doi:10.1126/science.1086887 · Cited by 1,065 · cited 2×
“We and others favour the view that histone deacetylation, histone methylation, DNA methylation and the production of small RNAs, all work together in various orders to bring about an efficient silent state (Grewal and Moazed, 2003).”
BackgroundMLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,053
Self-citationFischle, W., Wang, Y., Jacobs, S. A., Kim, Y., Allis, C. D., & Khorasanizadeh, S. (2003) · Genes & Development · doi:10.1101/gad.1110503 · Cited by 991
Self-citationRb targets histone H3 methylation and HP1 to promoters
Nielsen, S. J., Schneider, R., Bauer, U.-M., Bannister, A. J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R. E., et al. (2001) · Nature · doi:10.1038/35087620 · Cited by 904
Stabilization of Chromatin Structure by PRC1, a Polycomb Complex
Shao, Z., Raible, F., Mollaaghababa, R., Guyon, J. R., Wu, C.-T., Bender, W., & Kingston, R. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80604-2 · Cited by 822
Cheung, P., Tanner, K. G., Cheung, W. L., Sassone-Corsi, P., Denu, J. M., & Allis, C. D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80256-7 · Cited by 803
Self-citationHistone H2A variants H2AX and H2AZ
Redon, C., Pilch, D., Rogakou, E., Sedelnikova, O., Newrock, K., & Bonner, W. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00282-4 · Cited by 767
Histone methylation versus histone acetylation: new insights into epigenetic regulation
Rice, J. C., & Allis, C. D. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00208-8 · Cited by 703
Self-citationHistone acetylation and deacetylation in yeast
Kurdistani, S. K., & Grunstein, M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1075 · Cited by 677
Binary switches and modification cassettes in histone biology and beyond
Fischle, W., Wang, Y., & David Allis, C. (2003) · Nature · doi:10.1038/nature02017 · Cited by 629
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement
Su, I.-H., Basavaraj, A., Krutchinsky, A. N., Hobert, O., Ullrich, A., Chait, B. T., & Tarakhovsky, A. (2003) · Nature Immunology · doi:10.1038/ni876 · Cited by 611
Briggs, S. D., Bryk, M., Strahl, B. D., Cheung, W. L., Davie, J. K., Dent, S. Y. R., Winston, F., & Allis, C. D. (2001) · Genes & Development · doi:10.1101/gad.940201 · Cited by 595
Self-citationThe genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility
Celeste, A., Difilippantonio, S., Difilippantonio, M. J., Fernandez-Capetillo, O., Pilch, D. R., Sedelnikova, O. A., Eckhaus, M., Ried, T., Bonner, W. M., & Nussenzweig, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00567-1 · Cited by 551
Bannister, A. J., Schneider, R., & Kouzarides, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00798-5 · Cited by 539
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
Ayton, P. M., & Cleary, M. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204639 · Cited by 500
Bassing, C. H., Suh, H., Ferguson, D. O., Chua, K. F., Manis, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., & Alt, F. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00566-x · Cited by 482
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Ayton, P. M., & Cleary, M. L. (2003) · Genes & Development · doi:10.1101/gad.1111603 · Cited by 436
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418
Signaling Network Model of Chromatin
Schreiber, S. L., & Bernstein, B. E. (2002) · Cell · doi:10.1016/s0092-8674(02)01196-0 · Cited by 393
Ayyanathan, K., Lechner, M. S., Bell, P., Maul, G. G., Schultz, D. C., Yamada, Y., Tanaka, K., Torigoe, K., & Rauscher, F. J. (2003) · Genes & Development · doi:10.1101/gad.1102803 · Cited by 367
The role of DNA methylation in setting up chromatin structure during development
Hashimshony, T., Zhang, J., Keshet, I., Bustin, M., & Cedar, H. (2003) · Nature Genetics · doi:10.1038/ng1158 · Cited by 359
Zeitlin, S. G., Shelby, R. D., & Sullivan, K. F. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108125 · Cited by 330
Relevance of DNA methylation in the management of cancer
Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329
Histone H3 variants specify modes of chromatin assembly
Ahmad, K., & Henikoff, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172403699 · Cited by 325
Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N. A., Rowley, J. D., & Zeleznik-Le, N. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8732 · Cited by 319
Spectrum of hSNF5IINI1 Somatic Mutations in Human Cancer and Genotype-Phenotype Correlations
Sevenet, N., Lellouch-Tubiana, A., Schofield, D., Hoang-Xuan, K., Gessler, M., Birnbaum, D., Jeanpierre, C., Jouvet, A., & Delattre, O. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2359 · Cited by 305
Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer.
Tomonaga, T., Matsushita, K., Yamaguchi, S., 大橋, 建., Shimada, H., Ochiai, T., Yoda, K., & Nomura, F. (2003) · PubMed · Cited by 298
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287
Gene-Specific Targeting of H3K9 Methylation Is Sufficient for Initiating Repression In Vivo
Snowden, A. W., Gregory, P. D., Case, C. C., & Pabo, C. O. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01391-x · Cited by 268
Rozenblatt–Rosen, O., Rozovskaia, T., Burakov, D., Sedkov, Y., Tillib, S., Blechman, J., Nakamura, T., Croce, C. M., Mazo, A., & Canaani, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4152 · Cited by 239
Javed, A., Guo, B., Hiebert, S., Choi, J.-Y., Green, J., Zhao, S.-C., Osborne, M. A., Stifani, S., Stein, J. L., Lian, J. B., et al. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2221 · Cited by 233
When the SWI/SNF complex remodels … the cell cycle
Muchardt, C., & Yaniv, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204331 · Cited by 198
Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias
So, C. W., Lin, M., Ayton, P. M., Chen, E. H., & Cleary, M. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00188-0 · Cited by 196
Linking the Rb and Polycomb Pathways
Dahiya, A., Wong, S., Gonzalo, S., Gavin, M., & Dean, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00346-x · Cited by 195
Xia, Z.-B., Anderson, M., Diaz, M. O., & Zeleznik-Le, N. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1436338100 · Cited by 194
Role of protein methylation in chromatin remodeling and transcriptional regulation
Stallcup, M. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204325 · Cited by 191
ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job
Muchardt, C., & Yaniv, M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2999 · Cited by 179
Epigenomics and epigenetic therapy of cancer
Brown, R., & Strathdee, G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02314-6 · Cited by 172
Dimerization of MLL fusion proteins immortalizes hematopoietic cells
Martin, M. E., Milne, T. A., Bloyer, S., Galoian, K., Shen, W., Gibbs, D., Brock, H. W., Slany, R., & Hess, J. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00214-9 · Cited by 168
Hypomethylation: One Side of a Larger Picture
DUNN, B. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05960.x · Cited by 158
The role of MLL in hematopoiesis and leukemia
Ernst, P., Wang, J., & Korsmeyer, S. J. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00004 · Cited by 157
Histone methyltransferases, diet nutrients and tumour suppressors
Huang, S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc819 · Cited by 151
Protein Interactions of the MLL PHD Fingers Modulate MLL Target Gene Regulation in Human Cells
Fair, K., Anderson, M., Bulanova, E., Mi, H., Tropschug, M., & Dı́az, M. O. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3589-3597.2001 · Cited by 143
Structure of the SET domain histone lysine methyltransferase Clr4
Min, J., Zhang, X., Cheng, X., Grewal, S. I. S., & Xu, R.-M. (2002) · Nature Structural Biology · doi:10.1038/nsb860 · Cited by 130
The Nucleosome: A Powerful Regulator of Transcription
Wolffe, A. P., & Kurumizaka, H. (1998) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60832-6 · Cited by 114
Targeting DNA methylation in cancer
Szyf, M. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00012-6 · Cited by 101
Nie, Z., Yan, Z., Chen, E. H., Sechi, S., Ling, C., Zhou, S., Xue, Y., Yang, D., Murray, D., Kanakubo, E., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2942-2952.2003 · Cited by 88
The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex
Debernardi, S., Bassini, A., Jones, L. K., Chaplin, T., Linder, B., de Bruijn, D. R. H., Meese, E. U., & Young, B. D. (2002) · Blood · doi:10.1182/blood.v99.1.275 · Cited by 87
The EZH2 polycomb transcriptional repressor—a marker or mover of metastatic prostate cancer?
Sellers, W. R., & Loda, M. F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00187-3 · Cited by 87
Chromatin Modification, Leukaemia and Implications for Therapy
Jones, L. K., & Saha, V. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03586.x · Cited by 51
11q Deletions in Hematological Malignancies
Monni, O. M., & Knuutila, S. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109057924 · Cited by 49
Chromatin modifiers and tumor suppression
Klochendler‐Yeivin, A., & Yaniv, M. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00021-x · Cited by 43
Transcriptional Control: An Activating Role for Arginine Methylation
Davie, J. K., & Dent, S. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00674-1 · Cited by 36
Is medical genetics neglecting epigenetics?
Beaudet, A. L. (2002) · Genetics in Medicine · doi:10.1097/00125817-200209000-00013 · Cited by 23
Genetic lesions and perturbation of chromatin architecture: A road to cell transformation
Chakraborty, S., Senyuk, V. I., & Nucifora, G. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1165 · Cited by 21
Downs, J. A., & Jackson, S. P. (2003) · Nature · doi:10.1038/424732a · Cited by 20
Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond.
Coco, F. L., Zelent, A., Kimchi, A., Carducci, M., Gore, S. D., & Waxman, S. (2002) · PubMed · Cited by 20
Cited by
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
Nuclear structure in cancer cells
Zink, D., Fischer, A. H., & Nickerson, J. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1430 · Cited by 1,068
Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases
Whetstine, J. R., Nottke, A., Lan, F., Huarte, M., Smolikov, S., Chen, Z., Spooner, E., Li, E., Zhang, G., Colaiacovo, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.028 · Cited by 1,040
Metadata
- Authors
- Hake, S. B., Xiao, A., & Allis, C. D.
- Venue
- British Journal of Cancer
- Published
- 2004-02
- Volume
- 90
- Issue
- 4
- Pages
- 761-769
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2036256995
- Cited by
- 385
- References
- 77
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.